Abstract
Human mesenchymal stem/progenitor cells (MSPCs) are currently used in a large number of clinical trials aimed at regeneration or immune modulation. Despite a growing body of knowledge about MSPC biology and function, fundamental questions regarding the optimal manipulation procedure still remain unresolved. Due to biological, ethical, and safety reasons, the use of fetal bovine serum as a standard cell culture supplement has come under dispute inducing a search for comparable alternatives. A humanized culture system requires not only animal serum–free supplements for basal media but also animal protein–free additives like coating reagents or trypsin preparations. In comparison to other blood-derived substances, pooled human platelet lysate (pHPL) has been proven to be the most efficient stimulant for MSPC proliferation enabling the expansion of sufficiently high cell yields within a suitable timeframe. In this chapter, we introduce alternatives to avoid animal-derived factors in the clinical-grade MSPC production with a special emphasis on pHPL as a novel and promising cell culture supplement.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andia I (2006) New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 24:227–234
Augello A, De Bari C (2010) The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther 21:1226–1238
Baksh D, Yao R, Tuan RS (2007) Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384–1392
Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585–601
Bartmann C, Rohde E, Schallmoser K et al (2007) Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 47:1426–1435
Bernardo ME, Avanzini MA, Perotti C et al (2007) Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211:121–130
Bernardo ME, Avanzini MA, Ciccocioppo R et al (2009) Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn’s disease. Cytotherapy 11:825–836
Bianco P, Robey PG, Saggio I, Riminucci M (2010) “Mesenchymal” stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther 21:1057–1066
Bieback K, Hecker A, Kocaoemer A et al (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:2331–2341
Blande IS, Bassaneze V, Lavini-Ramos C et al (2009) Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 49:2680–2685
Borzini P, Mazzucco L (2005) Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms. Transfusion 45:1759–1767
Both SK, van der Muijsenberg AJ, van Blitterswijk CA, de Boer J, de Bruijn JD (2007) A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng 13:3–9
Brunner D, Frank J, Appl H, Schöffl H, Pfaller W, Gstraunthaler G (2010) Serum-free cell culture: the serum-free media interactive online database. ALTEX 27:53–62
Butler M, Christie A (1994) Adaptation of mammalian cells to non-ammoniagenic media. Cytotechnology 15:87–94
Capelli C, Domenghini M, Borleri G et al (2007) Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 40:785–791
Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM et al (2008) Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 36:1014–1021
Carvalho PP, Wu X, Yu G et al (2011) Use of animal protein-free products for passaging adherent human adipose-derived stromal/stem cells. Cytotherapy 13:594–597
Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC (2010) A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 1:8
Chevallier N, Anagnostou F, Zilber S et al (2010) Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 31:270–278
Cohnheim J (1867) Ueber Entzündung und Eiterung. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin 40:1–79
Colter DC, Class R, DiGirolamo CM, Prockop DJ (2000) Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97:3213–3218
Colter DC, Sekiya I, Prockop DJ (2001) Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98:7841–7845
Cooke MJ, Phillips SR, Shah DS, Athey D, Lakey JH, Przyborski SA (2008) Enhanced cell attachment using a novel cell culture surface presenting functional domains from extracellular matrix proteins. Cytotechnology 56:71–79
Crespo-Diaz R, Behfar A, Butler GW et al (2010) Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant 20:797–811
Crisan M, Yap S, Casteilla L et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301–313
da Silva ML, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204–2213
da Silva ML, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287–2299
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317
Doucet C, Ernou I, Zhang YZ et al (2005) Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205:228–236
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37:2259–2272
Frechette JP, Martineau I, Gagnon G (2005) Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 84:434–439
Friedenstein AJ, Chailakhyan RK, Latsinik NV et al (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17:331–340
Giusti I, Rughetti A, D’Ascenzo S et al (2009) Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion 49:771–778
Hofmann NA, Reinisch A, Strunk D (2009) Isolation and large scale expansion of adult human endothelial colony forming progenitor cells. J Vis Exp 32. doi:10.3791/1524
Horn P, Bokermann G, Cholewa D et al (2010) Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12:888–898
Horwitz EM, Gordon PL, Koo WK et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937
Jung J, Moon N, Ahn JY et al (2009) Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev 18:559–571
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294–1301
Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N (2007) Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 40:522–528
Kleinman HK, Luckenbill-Edds L, Cannon FW, Sephel GC (1987) Use of extracellular matrix components for cell culture. Anal Biochem 166:1–13
Kocaoemer A, Kern S, Klueter H, Bieback K (2007) Human AB-serum as well as thrombin-activated platelet-rich-plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25:1270–1278
Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR (2007) Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213:18–26
Lindner U, Kramer J, Behrends J et al (2010) Improved proliferation and differentiation capacity of human mesenchymal stromal cells cultured with basement-membrane extracellular matrix proteins. Cytotherapy 12:992–1005
Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A (2000) Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 49:152–156
Mannello F, Tonti GA (2007) Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25:1603–1609
Martinez-Zapata MJ, Marti-Carvajal A, Sola I et al (2009) Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion 49:44–56
Mazzucco L, Borzini P, Gope R (2010) Platelet-derived factors involved in tissue repair-from signal to function. Transfus Med Rev 24:218–234
Meuleman N, Tondreau T, Delforge A et al (2006) Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur J Haematol 76:309–316
Mosna F, Sensebe L, Krampera M (2010) Human bone marrow and adipose tissue mesenchymal stem cells: a user’s guide. Stem Cells Dev 19:1449–1470
Muller I, Kordowich S, Holzwarth C et al (2006) Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8:437–444
Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E (2008) Platelets and wound healing. Front Biosci 13:3532–3548
Perez-Ilzarbe M, Diez-Campelo M, Aranda P et al (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49:1901–1910
Phadnis SM, Joglekar MV, Venkateshan V, Ghaskadbi SM, Hardikar AA, Bhonde RR (2006) Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells. In Vitro Cell Dev Biol Anim 42:283–286
Pieri F, Lucarelli E, Corinaldesi G et al (2009) Effect of mesenchymal stem cells and platelet-rich plasma on the healing of standardized bone defects in the alveolar ridge: a comparative histomorphometric study in minipigs. J Oral Maxillofac Surg 67:265–272
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Prins HJ, Rozemuller H, Vonk-Griffioen S et al (2009) Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng Part A 15:3741–3751
Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74
Rebelatto CK, Aguiar AM, Moretao MP et al (2008) Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233:901–913
Reinisch A, Strunk D (2009) Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). J Vis Exp 32. doi:10.3791/1525
Reinisch A, Bartmann C, Rohde E et al (2007) Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2:371–382
Reinisch A, Hofmann NA, Obenauf AC et al (2009) Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 113:6716–6725
Rohde E, Schallmoser K, Bartmann C et al (2008) GMP-compliant propagation of human multipotent mesenchymal stromal cells. In: Gad SC (ed) Pharmaceutical manufacturing handbook: regulations and quality. Wiley, New Jersey
Sacchetti B, Funari A, Michienzi S et al (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324–336
Sauerbier S, Stricker A, Kuschnierz J et al (2010) In vivo comparison of hard tissue regeneration with human mesenchymal stem cells processed with either the FICOLL method or the BMAC method. Tissue Eng Part C 16:215–223
Schallmoser K, Strunk D (2009) Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J Vis Exp 32. doi:10.3791/1523
Schallmoser K, Strunk D (2011) Generation of a pool of human platelet lysate (pHPL) and efficient use in cell culture. In: Methods in molecular biology. Humana Press, in press
Schallmoser K, Bartmann C, Rohde E et al (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47:1436–1446
Schallmoser K, Rohde E, Reinisch A et al (2008) Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C 14:185–196
Schallmoser K, Bartmann C, Rohde E et al (2010) Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica 95:867–874
Selvaggi TA, Walker RE, Fleisher TA (1997) Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89:776–779
Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23:1357–1366
Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462–4671
Tarte K, Gaillard J, Lataillade JJ et al (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115:1549–1553
Tolar J, Le Blanc K, Keating A, Blazar BR (2010) Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28:1446–1455
Tonti GA, Mannello F (2008) From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol 52:1023–1032
Wagner W, Ho AD (2007) Mesenchymal stem cell preparations–comparing apples and oranges. Stem Cell Rev 3:239–248
Weibrich G, Kleis WK, Hafner G, Hitzler WE (2002) Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30:97–102
Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T (2004) Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10:955–964
Zaky SH, Ottonello A, Strada P, Cancedda R, Mastrogiacomo M (2008) Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2:472–481
Zuk PA, Zhu M, Ashjian P et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295
Acknowledgments
This work was supported by the Austrian Research Foundation (FWF, grant N211-NAN; DS) and the Adult Stem Cell Research Foundation (KS). The authors thank Claudia Url, Daniela Thaler, Margret Frühwirth, and Birgit Feilhauer for excellent technical assistance and Monica Farrell for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schallmoser, K., Etchart, N., Strunk, D., Rohde, E. (2012). Animal Protein–Free Expansion of Human Mesenchymal Stem/Progenitor Cells. In: Allan, D., Strunk, D. (eds) Regenerative Therapy Using Blood-Derived Stem Cells. Stem Cell Biology and Regenerative Medicine. Humana Press. https://doi.org/10.1007/978-1-61779-471-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-61779-471-1_5
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-470-4
Online ISBN: 978-1-61779-471-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)